Local Injections of Adipose-Derived Mesenchymal Stem Cells Modulate Inflammation and Increase Angiogenesis Ameliorating the Dystrophic Phenotype in Dystrophin-Deficient Skeletal Muscle

Stem Cell Reviews and Reports

Volumn 8, Issue 2, 2012, Pages 363-374

  da Pinheiro, Carlos Hermano Justa ^a,b   de Queiroz, Jean César Farias ^a   Guimarães Ferreira, Lucas ^a   Vitzel, Kaio Fernando ^a,b   Nachbar, Renato Tadeu ^a,b   de Sousa, Luís Gustavo Oliveira ^a   de Souza Jr, Alcione Lescano ^a   Nunes, Maria Tereza ^a   Curi, Rui ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Network of Cellular Therapy (RNTC)   (Brazil)

Author keywords

Angiogenesis; Cytokines; Inflammation; Mesenchymal stem cells; Muscular dystrophy; Skeletal muscle function; Stem cell transplantation

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CYTOKINE; DYSTROPHIN; MYOGENIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; C57BL MOUSE; CYTOLOGY; INFLAMMATION; INJECTION; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CYTOKINES; DYSTROPHIN; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS; MACROPHAGES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOGENIN; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84861702531     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9304-0     Document Type: Article

References (54)

1. Leturcq, F., & Kaplan, J. C. (2005). Molecular bases of dystrophinopathies. J Soc Biol, 199, 5-11.
2. Burghes, A. H., Logan, C., Hu, X., et al. (1987). A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature, 328, 434-437.
3. Ferrari, G., Cusella-De Angelis, G., & Coletta, M. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 279, 1528-1530.
4. Gussoni, E., Soneoka, Y., Strickland, C. D., et al. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 401, 390-394.
5. McKinney-Freeman, S. L., Jackson, K. A., Camargo, F. D., et al. (2002). Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA, 99, 1341-1346.
6. Fukada, S., Miyagoe-Suzuki, Y., Tsukihara, H., et al. (2002). Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice. J Cell Sci, 115, 1285-1293.
7. LaBarge, M. A., & Blau, H. M. (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell, 111, 589-601.
8. Camargo, F. D., Green, R., Capetanaki, Y., et al. (2003). Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med, 9, 1520-1527.
9. Corbel, S. Y., Lee, A., Yi, L., et al. (2003). Contribution of hematopoietic stem cells to skeletal muscle. Nat Med, 9, 1528-1532.
10. Bachrach, E., Li, S., Perez, A. L., et al. (2004). Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci USA, 101, 3581-3586.
11. Wakitani, S., Saito, T., & Caplan, A. I. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 18, 1417-1426.
12. Gonçalves, M. A., de Vries, A. A., Holkers, M., et al. (2006). Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum Mol Genet, 15, 213-221.
13. Zuk, P. A., Zhu, M., Mizuno, H., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 7, 211-228.
14. Rodriguez, A. M., Elabd, C., Amri, E. Z., et al. (2005). Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med, 201, 1397-1405.
15. Vieira, N. M., Bueno, C. R., Jr., Brandalise, V., et al. (2008). SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem Cells, 26, 2391-2398.
16. Bacou, F., el Andalousi, R. B., Daussin, P. A., et al. (2004). Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle. Cell Transplant, 13, 103-111.
17. Lee, J. H., & Kemp, D. M. (2006). Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun, 341, 882-888.
18. Di Rocco, G., Iachininoto, M. G., Tritarelli, A., et al. (2006). Myogenic potential of adipose-tissue-derived cells. J Cell Sci, 119, 2945-2952.
19. Vieira, N. M., Brandalise, V., Zucconi, E., et al. (2008). Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Biol Cell, 100, 231-241.
20. Messina, S., Mazzeo, A., Bitto, A., et al. (2007). VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. FASEB J, 21, 3737-3746.
21. Gargioli, C., Coletta, M., De Grandis, F., et al. (2008). PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat Med, 14, 973-978.
22. Rando, T. A. (2008). Turning back time: reversing tissue pathology to enhance stem cell engraftment. Cell Stem Cell, 3, 232-234.
23. Pinheiro, C. H., Vitzel, K. F., & Curi, R. (2010). Effect of N-acetylcysteine on markers of skeletal muscle injury after fatiguing contractile activity. Scand J Med Sci Sports. doi: 10. 1111/j. 1600-0838. 2010. 01143. x.
24. Bassit, R. A., Pinheiro, C. H., Vitzel, K. F., et al. (2010). Effect of short-term creatine supplementation on markers of skeletal muscle damage after strenuous contractile activity. Eur J Appl Physiol, 108, 945-955.
25. Chamberlain, J. S., Metzger, J., Reyes, M., et al. (2007). Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J, 21, 2195-2204.
26. Moser, H. (1984). Review of studies on the proportion and origin of new mutants in Duchenne muscular dystrophy. In L. P. Ten Kate, P. L. Pearson, & A. M. Stadhouders (Eds.), Research into the Origin and Treatment of Muscular Dystrophy (pp. 41-52). Amsterdam: Excerpta Medica.
27. Lynch, G. S., Hinkle, R. T., Chamberlain, J. S., et al. (2001). Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol, 535, 591-600.
28. Gnecchi, M., Zhang, Z., Ni, A., et al. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 103, 1204-1219.
29. Lecarpentier, Y. (2007). Physiological role of free radicals in skeletal muscles. J Appl Physiol, 103, 1917-1918.
30. Irintchev, A. (1987). Muscle damage and repair in voluntarily running mice: strain and muscle differences. Cell Tissue Res, 249, 509-521.
31. Mendell, J. R. (1971). Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science, 172, 1143-1145.
32. Louboutin, J. P., Rouger, K., Tinsley, J. M., et al. (2001). iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Mol Med, 7, 355-364.
33. Bredt, D., & Snyder, S. (1994). Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem, 63, 175-195.
34. Kobzik, L., Reid, M., Bredt, D., et al. (1994). Nitric oxide in skeletal muscle. Nature, 372, 546-548.
35. Ischiropoulos, H. (1998). Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys, 356, 1-11.
36. Wehling, M., Spencer, M. J., & Tidball, J. G. (2001). A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol, 155, 123-131.
37. Gurpur, P. B., Liu, J., Burkin, D. J., et al. (2009). Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy. Am J Pathol, 174, 999-1008.
38. Chung, J., Grammer, T. C., Lemon, K. P., et al. (1994). PDGF- and insulin-dependent pp 70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature, 370, 71-75.
39. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701-705.
40. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA, 98, 10344-10349.
41. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822.
42. Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem, 98, 1076-1084.
43. Tang, Y. L., Zhao, Q., Qin, X., et al. (2005). Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg, 80, 229-236.
44. Togel, F., Hu, Z., Weiss, K., et al. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol, 289, F31-F42.
45. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., et al. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109, 1292-1298.
46. Al-Khaldi, A., Al-Sabti, H., Galipeau, J., et al. (2003). Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg, 75, 204-209.
47. Nagaya, N., Fujii, T., Iwase, T., et al. (2004). Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol, 287, H2670-H2676.
48. Nagaya, N., Kangawa, K., Itoh, T., et al. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112, 1128-1135.
49. Wehling-Henricks, M., Lee, J. J., & Tidball, J. G. (2004). Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle. Neuromuscul. Disord., 14, 483-490.
50. Messina, S., Bitto, A., Aguennouz, M., et al. (2006). Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol, 198(1), 234-241.
51. Tidball, J. G., & Wehling-Henricks, M. (2007). Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol., 578(Pt 1), 327-336.
52. Vetrone, S. A., Montecino-Rodriguez, E., Kudryashova, E., et al. (2009). Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest., 119(6), 1583-1594.
53. Barbul, A., Lazarou, S. A., Efron, D. T., et al. (1990). Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery, 108, 331-337.
54. Wehling-Henricks, M., Jordan, M. C., Gotoh, T., et al. (2010). Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One., 5(5), e10763.